Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.38 USD | +1.59% | +0.86% | -10.75% |
21/05 | JPMorgan Starts Structure Therapeutics With Overweight Rating | MT |
09/05 | Structure Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.75% | 166.94Cr | |
+9.99% | 11TCr | |
+12.01% | 11TCr | |
-3.07% | 2.22TCr | |
-0.67% | 2.13TCr | |
-4.64% | 1.88TCr | |
-6.90% | 1.75TCr | |
-39.36% | 1.72TCr | |
+5.82% | 1.41TCr | |
+33.05% | 1.22TCr |
- Stock Market
- Equities
- GPCR Stock
- News Structure Therapeutics Inc.
- Piper Sandler Raises Price Target on Structure Therapeutics to $93 From $58, Maintains Overweight Rating